CAC2 Childhood Cancer Community News Digest (December 13-19)
Assorted news from last week:
An immunotherapy harnessing the immune system’s “natural killer” cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at Washington University School of Medicine in St. Louis have shown, in a small clinical trial, that the same natural killer cells also can help some children and young adults with recurrent AML and few other treatment options.
Upcoming Webinars and Online Opportunities:
Please register to attend the 10th ACCELERATE Paediatric Oncology Conference, February 10-11 2022 (EU afternoons, US mornings). The annual ACCELERATE Conference aims to strengthen international cooperation between academia, parent groups, biopharma companies, regulatory bodies and HTA bodies to improve and speed up the global development of new paediatric oncology drugs.
Categories
- Blog Posts (60)
- Guest Blogs (8)
- Member Blogs (23)
- Survivorship Matters Blog (7)
- CAC2 News (13)
- Collaborative Achievements (14)
- Community News (111)
- Research Explained (6)
- Webinars (59)
Tags
#CancelChildhoodCancer
Advocacy
Annual Summit
Awareness
AYA
Best Practices
Biorepositories
CAC2 News
CAC2 Projects
Call to Action
Clinical Trials
Collaboration
Data
Delayed Diagnosis
Digest
Drug Development
Drug Shortages
Ethics
Family Support
FDA
Global News
Member Access
Nutrition
Prevention
project incubator
Psychosocial Support
Rare Cancers
Regulations
Research
research advocacy collaboration
Survivorship
Venture Philanthropy